BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38698475)

  • 21. Correlation analysis of metabolic characteristics and the risk of metabolic-associated fatty liver disease - related hepatocellular carcinoma.
    Xie X; Zheng M; Guo W; Zhou Y; Xiang Z; Li Y; Yang J
    Sci Rep; 2022 Aug; 12(1):13969. PubMed ID: 35978032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic dysfunction-associated fatty liver disease and the risk of hepatocellular carcinoma.
    Song BG; Choi SC; Goh MJ; Kang W; Sinn DH; Gwak GY; Paik YH; Choi MS; Lee JH; Paik SW
    JHEP Rep; 2023 Sep; 5(9):100810. PubMed ID: 37538246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Hepatic Steatosis on Disease-Free Survival in Patients with Non-B Non-C Hepatocellular Carcinoma Undergoing Hepatic Resection.
    Nishio T; Hatano E; Sakurai T; Taura K; Okuno M; Kasai Y; Seo S; Yasuchika K; Mori A; Kaido T; Uemoto S
    Ann Surg Oncol; 2015 Jul; 22(7):2226-34. PubMed ID: 25395147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinguished prognosis after hepatectomy of HBV-related hepatocellular carcinoma with or without cirrhosis: a long-term follow-up analysis.
    Yang SL; Liu LP; Sun YF; Yang XR; Fan J; Ren JW; Chen GG; Lai PB
    J Gastroenterol; 2016 Jul; 51(7):722-32. PubMed ID: 26607653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Clinical Value of Postoperative Transarterial Chemoembolization for Resectable Patients with Intermediate Hepatocellular Carcinoma After Radical Hepatectomy: a Propensity Score-Matching Study.
    Wang L; Lin N; Lin K; Xiao C; Wang R; Chen J; Zhou W; Liu J
    J Gastrointest Surg; 2021 May; 25(5):1172-1183. PubMed ID: 32440804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HBV is a risk factor for poor patient prognosis after curative resection of hepatocellular carcinoma: A retrospective case-control study.
    Li Z; Zhao X; Jiang P; Xiao S; Wu G; Chen K; Zhang X; Liu H; Han X; Wang S; Li X
    Medicine (Baltimore); 2016 Aug; 95(31):e4224. PubMed ID: 27495026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic dysfunction-associated fatty liver disease increases risk of adverse outcomes in patients with chronic hepatitis B.
    van Kleef LA; Choi HSJ; Brouwer WP; Hansen BE; Patel K; de Man RA; Janssen HLA; de Knegt RJ; Sonneveld MJ
    JHEP Rep; 2021 Oct; 3(5):100350. PubMed ID: 34557660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatectomy for huge hepatocellular carcinoma in 634 cases.
    Chen XP; Qiu FZ; Wu ZD; Zhang BX
    World J Gastroenterol; 2006 Aug; 12(29):4652-5. PubMed ID: 16937434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intermediate-stage hepatocellular carcinoma patients with a high HBV-DNA load may benefit from postoperative anti-hepatitis B virus therapy.
    Rui S; Yan J; Zhang H; Wang Z; Zhou W
    Medicine (Baltimore); 2017 Jul; 96(30):e7608. PubMed ID: 28746212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis B virus reactivation after radiofrequency ablation or hepatic resection for HBV-related small hepatocellular carcinoma: a retrospective study.
    Dan JQ; Zhang YJ; Huang JT; Chen MS; Gao HJ; Peng ZW; Xu L; Lau WY
    Eur J Surg Oncol; 2013 Aug; 39(8):865-72. PubMed ID: 23597497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diabetes mellitus and increased postoperative risk of acute renal failure after hepatectomy for hepatocellular carcinoma: a nationwide population-based study.
    Tsai MS; Lin CL; Chang SN; Lee PH; Kao CH
    Ann Surg Oncol; 2014 Nov; 21(12):3810-6. PubMed ID: 24841349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gamma-glutamyl transpeptidase to platelet ratio predicts short-term outcomes in hepatocellular carcinoma patients undergoing minor liver resection.
    Ke MY; Zhang M; Su Q; Wei S; Zhang J; Wang Y; Wu R; Lv Y
    J Surg Res; 2018 Nov; 231():403-410. PubMed ID: 30278960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NAFLD and MAFLD as emerging causes of HCC: A populational study.
    Myers S; Neyroud-Caspar I; Spahr L; Gkouvatsos K; Fournier E; Giostra E; Magini G; Frossard JL; Bascaron ME; Vernaz N; Zampaglione L; Negro F; Goossens N
    JHEP Rep; 2021 Apr; 3(2):100231. PubMed ID: 33748726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of Steatosis on Prognosis of Patients with Early-Stage Hepatocellular Carcinoma After Hepatic Resection.
    Su CW; Chau GY; Hung HH; Yeh YC; Lei HJ; Hsia CY; Lai CR; Lin HC; Wu JC
    Ann Surg Oncol; 2015 Jul; 22(7):2253-61. PubMed ID: 25490872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of RETREAT and CCFSS Scoring Systems for Risk Estimation of Hepatocellular Carcinoma Recurrence After Radical Resection.
    Zhang S; Zhang X; Mo C; Luo Y
    Altern Ther Health Med; 2023 Nov; 29(8):694-698. PubMed ID: 37678878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes of Hepatic Resection for Hepatocellular Carcinoma Associated with Portal Vein Invasion.
    Shehta A; Farouk A; Elghawalby AN; Elshobary M; Aboelenin A; Fouad A; Ali MA
    J Surg Res; 2021 Oct; 266():269-283. PubMed ID: 34038849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact and usefulness of the transition to the new MAFLD classification for non-B, non-C HCC: a retrospective cohort study.
    Johira Y; Nakahara T; Kinami T; Yamasaki S; Kosaka M; Shirane Y; Miura R; Murakami S; Yano S; Amioka K; Naruto K; Ando Y; Kosaka Y; Kodama K; Uchikawa S; Fujino H; Ono A; Murakami E; Okamoto W; Yamauchi M; Kawaoka T; Hayes CN; Tsuge M; Imamura M; Aikata H; Oka S
    BMC Gastroenterol; 2023 Jun; 23(1):222. PubMed ID: 37380950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of metabolic dysfunction-associated fatty liver disease on liver cancer risk in a population with chronic hepatitis B virus infection: A nationwide study.
    Yun B; Ahn SH; Oh J; Yoon JH; Kim BK
    Hepatol Res; 2022 Dec; 52(12):975-984. PubMed ID: 35976670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hepatic resection for hepatocellular carcinoma--results and analysis of the current literature].
    Neeff H; Makowiec F; Harder J; Gumpp V; Klock A; Thimme R; Drognitz O; Hopt UT
    Zentralbl Chir; 2009 Apr; 134(2):127-35. PubMed ID: 19382043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hierarchic Interaction of Factors Associated With Liver Decompensation After Resection for Hepatocellular Carcinoma.
    Citterio D; Facciorusso A; Sposito C; Rota R; Bhoori S; Mazzaferro V
    JAMA Surg; 2016 Sep; 151(9):846-53. PubMed ID: 27248425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.